about
Potent diuretic effects of prednisone in heart failure patients with refractory diuretic resistanceA specifically designed nanoconstruct associates, internalizes, traffics in cardiovascular cells, and accumulates in failing myocardium: a new strategy for heart failure diagnostics and therapeuticsAnthracycline induced cardiotoxicity: biomarkers and "Omics" technology in the era of patient specific care.Effect of tumor necrosis factor-α on ventricular arrhythmias in rats with acute myocardial infarction in vivo.The role of MEKK1 in hypertrophic cardiomyopathy.Cardioprotection and lifespan extension by the natural polyamine spermidine.Comparison of the effects of exercise participation on psychosocial risk factors and cardiovascular disease in women.Shenfu Injection suppresses inflammation by targeting haptoglobin and pentraxin 3 in rats with chronic ischemic heart failure.Increase of plasma IL-9 and decrease of plasma IL-5, IL-7, and IFN-γ in patients with chronic heart failureChanges in Glucose, TNF-α and IL-6 Blood Levels in Middle-aged Women Associated with Aerobic Exercise and Meditation TrainingBiomarkers of myocardial stress and systemic inflammation in patients who engage in heart failure self-care management.Oxidative Stress and Inflammation in Heart Disease: Do Antioxidants Have a Role in Treatment and/or Prevention?Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.Vitamin D deficiency contributes to the reduction and impaired function of naïve CD45RA⁺ regulatory T cell in chronic heart failureInterferon-gamma induces chronic active myocarditis and cardiomyopathy in transgenic mice.Gout, not hyperuricemia alone, impairs left ventricular diastolic function.Ventricular-assist devices for the treatment of chronic heart failure.Type D personality as a prognostic factor in heart disease: assessment and mediating mechanisms.Pilot Randomized Study of a Gratitude Journaling Intervention on Heart Rate Variability and Inflammatory Biomarkers in Patients With Stage B Heart Failure.Is CaMKII a link between inflammation and hypertrophy in heart?Protein-losing enteropathy after Fontan operation.Tumor necrosis factor-alpha and mortality in heart failure: a community study.Common variants in IL-17A/IL-17RA axis contribute to predisposition to and progression of congestive heart failure.Prognostic value of biomarkers in heart failure: application of novel methods in the community.Background and design of the profiling biobehavioral responses to mechanical support in advanced heart failure study.Intravenous administration of puppy deciduous teeth stem cells in degenerative valve disease.MicroRNA involvement in immune activation during heart failure.The role of monocytes and inflammation in the pathophysiology of heart failure.The immunological axis in heart failure: importance of the leukocyte differential.Role of tumor necrosis factor alpha in the pathogenesis of atrial fibrillation: A novel potential therapeutic target?Unmet Needs in the Pathogenesis and Treatment of Cardiovascular Comorbidities in Chronic Inflammatory Diseases.Does the pathophysiology of heart failure prime the incidence of cancer?Are there differences in acute phase inflammation markers regarding the type of heart failure?Increased interleukin-6 but not tumour necrosis factor-alpha predicts mortality in the population of elderly heart failure patients.Cardiotrophin-1 induces tumor necrosis factor alpha synthesis in human peripheral blood mononuclear cellsAutoantibody profiling on a plasmonic nano-gold chip for the early detection of hypertensive heart disease.Infection, Oxidative Stress, and Changes in Circulating Regulatory T Cells of Heart Failure Patients Supported by Continuous-Flow Ventricular Assist Devices.Monocytic fibroblast precursors mediate fibrosis in angiotensin-II-induced cardiac hypertrophy.Aerobic exercise improves the inflammatory profile correlated with cardiac remodeling and function in chronic heart failure rats.Heart-kidney crosstalk and role of humoral signaling in critical illness
P2860
Q24644755-2BF348B4-17C2-4162-9D4A-1441769EC042Q30802055-E61D2005-AF45-4DF2-A213-3539FC727AA0Q33658456-6A20BC52-95E5-4CF3-858B-637E89BE966CQ34031992-842157BB-4F71-4A89-A09C-DB36C1C680A2Q34286589-C3D5DE4F-8097-403C-BB3E-5A510E07BC05Q34544613-3265B907-6058-410D-9366-426C8CDE79F0Q34567294-C1CB6A22-B25E-4D0A-915B-1C39CF882126Q34620837-447E9834-9B34-4EBD-B6A1-A12BA38B2C5FQ34748917-07AC51C1-1511-4FFF-AA1D-A63CF4C4B5A8Q34750239-690A0ADA-DC50-46E8-8394-0EDC5155685EQ35043024-4D880175-AC9C-41F8-A83F-A7FC09E9C031Q35167634-2044A23F-6267-4730-8343-D1C7FB0962F9Q35190449-E59DB864-84A0-499A-86D2-8D44B3B66E36Q35578732-1B6D8AEA-DE1D-4CB4-8FB6-C214C8D97FDBQ35915997-9445DD23-964C-457E-BF04-A1EA1935833FQ36278529-254FFA47-CBDF-4086-8B7F-F0413FBF275BQ36815993-3B3AC4DE-96E1-4C86-B4FF-44BAFB403A5BQ37000719-EDB3947C-0B24-404C-9C2F-15B03688EF9EQ37053053-1F995807-4552-4E17-88AF-580A9CD4A49BQ37064322-A4B2028F-4E9B-4E6D-A2FA-F6865E37C8B0Q37123517-A102E9F1-A693-4212-88B8-1F566775B6BBQ37192858-1B6D85CC-450D-455D-8EF8-EAB8FFD47778Q37328076-15ACB922-0A2F-4ABE-A10F-D9BE3948B790Q37413803-4DAB14B1-BF40-4F64-9142-953417F369C4Q37452892-A6639A76-C866-4ACA-B564-BEF2F88DB228Q37584758-ADDCD182-8DE3-461F-9817-D101CCAED68FQ37866669-BB3F0E5D-1888-4437-9097-89DE8C70093BQ37939658-5B6CCAB5-3030-42EB-8B7D-A8B349D0C5E5Q38051119-DE535DB6-24AE-45A2-9E43-6C65F6F303F8Q38486305-76B09F36-EA7B-4F2A-86CB-AB0A35602D6DQ38663003-619BDD2A-05EE-492A-B9F1-A255955A82E8Q38851473-C24CF46E-FE20-4651-8EB0-F2137BAD3189Q38899162-20261593-C396-415B-97D1-0822CDA3483CQ39418050-FAD23035-3DAF-44AA-AEFD-53A4A7B0E026Q39542085-BC20D9BE-17F8-4B62-B9D4-E1F0F13A6F7CQ40153619-218C6F3D-CBB1-4BAA-A74C-729D9464F9DFQ40421756-9F669F4E-EE05-417F-878D-A9E8D8F18328Q42097897-1DDF1AA3-09FB-4B66-9FBD-CE1C5EC6AEBCQ42142166-C2568143-617A-43B4-A2E0-9500258A568FQ42696824-6FAFA358-92F4-4D5C-A14B-4BEEB169BF8E
P2860
description
2005 nî lūn-bûn
@nan
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
2005年论文
@zh
2005年论文
@zh-cn
name
Immune activation in chronic heart failure.
@ast
Immune activation in chronic heart failure.
@en
type
label
Immune activation in chronic heart failure.
@ast
Immune activation in chronic heart failure.
@en
prefLabel
Immune activation in chronic heart failure.
@ast
Immune activation in chronic heart failure.
@en
P1476
Immune activation in chronic heart failure.
@en
P2093
Guillermo Torre-Amione
P304
3C-8C; discussion 38C-40C
P356
10.1016/J.AMJCARD.2005.03.006
P407
P577
2005-06-01T00:00:00Z